Free Trial

ImmunoPrecise Antibodies (IPA) Competitors

ImmunoPrecise Antibodies logo
$1.76 +0.13 (+7.98%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.73 -0.03 (-1.70%)
As of 07:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IPA vs. DSGN, VOR, ACIU, ESPR, PROK, KOD, SLS, LRMR, CRGX, and CYBN

Should you be buying ImmunoPrecise Antibodies stock or one of its competitors? The main competitors of ImmunoPrecise Antibodies include Design Therapeutics (DSGN), Vor Biopharma (VOR), AC Immune (ACIU), Esperion Therapeutics (ESPR), ProKidney (PROK), Kodiak Sciences (KOD), SELLAS Life Sciences Group (SLS), Larimar Therapeutics (LRMR), CARGO Therapeutics (CRGX), and Cybin (CYBN). These companies are all part of the "pharmaceutical products" industry.

ImmunoPrecise Antibodies vs. Its Competitors

Design Therapeutics (NASDAQ:DSGN) and ImmunoPrecise Antibodies (NASDAQ:IPA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Design Therapeutics has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Comparatively, ImmunoPrecise Antibodies has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.

Design Therapeutics presently has a consensus target price of $4.00, suggesting a potential upside of 9.89%. ImmunoPrecise Antibodies has a consensus target price of $4.00, suggesting a potential upside of 127.27%. Given ImmunoPrecise Antibodies' stronger consensus rating and higher possible upside, analysts plainly believe ImmunoPrecise Antibodies is more favorable than Design Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Design Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
ImmunoPrecise Antibodies
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Design Therapeutics has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -190.76%. Design Therapeutics' return on equity of -22.85% beat ImmunoPrecise Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Design TherapeuticsN/A -22.85% -22.02%
ImmunoPrecise Antibodies -190.76%-88.87%-49.26%

56.6% of Design Therapeutics shares are owned by institutional investors. Comparatively, 6.7% of ImmunoPrecise Antibodies shares are owned by institutional investors. 31.2% of Design Therapeutics shares are owned by insiders. Comparatively, 6.8% of ImmunoPrecise Antibodies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, ImmunoPrecise Antibodies had 3 more articles in the media than Design Therapeutics. MarketBeat recorded 3 mentions for ImmunoPrecise Antibodies and 0 mentions for Design Therapeutics. ImmunoPrecise Antibodies' average media sentiment score of 0.68 beat Design Therapeutics' score of 0.00 indicating that ImmunoPrecise Antibodies is being referred to more favorably in the news media.

Company Overall Sentiment
Design Therapeutics Neutral
ImmunoPrecise Antibodies Positive

ImmunoPrecise Antibodies has higher revenue and earnings than Design Therapeutics. Design Therapeutics is trading at a lower price-to-earnings ratio than ImmunoPrecise Antibodies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Design TherapeuticsN/AN/A-$49.59M-$0.99-3.68
ImmunoPrecise Antibodies$18.16M4.43-$20.13M-$1.16-1.52

Summary

ImmunoPrecise Antibodies beats Design Therapeutics on 8 of the 15 factors compared between the two stocks.

Get ImmunoPrecise Antibodies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IPA vs. The Competition

MetricImmunoPrecise AntibodiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$74.60M$1.97B$5.47B$8.95B
Dividend YieldN/AN/A5.25%4.04%
P/E Ratio-1.5235.7726.9920.11
Price / Sales4.4311.18428.71119.81
Price / CashN/A54.5536.8257.86
Price / Book1.898.567.985.56
Net Income-$20.13M-$62.39M$3.16B$248.40M
7 Day Performance66.04%4.26%2.38%4.67%
1 Month Performance162.77%4.34%2.17%6.64%
1 Year Performance77.78%9.18%33.81%21.31%

ImmunoPrecise Antibodies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IPA
ImmunoPrecise Antibodies
2.528 of 5 stars
$1.76
+8.0%
$4.00
+127.3%
+76.0%$74.60M$18.16M-1.5280News Coverage
DSGN
Design Therapeutics
0.3745 of 5 stars
$3.37
-5.6%
$4.00
+18.7%
+4.0%$202.66MN/A-3.4040Positive News
VOR
Vor Biopharma
3.9425 of 5 stars
$1.62
+52.8%
$5.63
+247.4%
+164.9%$202.44MN/A-0.98140Options Volume
Gap Up
High Trading Volume
ACIU
AC Immune
2.7562 of 5 stars
$2.03
+1.0%
$12.00
+491.1%
-40.5%$201.82M$31.02M-3.50140
ESPR
Esperion Therapeutics
4.2296 of 5 stars
$0.98
-0.9%
$7.00
+611.1%
-51.3%$196.93M$332.31M-1.23200Positive News
PROK
ProKidney
0.7394 of 5 stars
$0.59
-11.5%
$3.50
+491.1%
+68.8%$195.73M$80K-0.993Trending News
Gap Up
High Trading Volume
KOD
Kodiak Sciences
4.1301 of 5 stars
$3.73
+0.8%
$9.00
+141.3%
+58.5%$195.23MN/A-1.0390News Coverage
SLS
SELLAS Life Sciences Group
0.1249 of 5 stars
$2.19
+12.3%
N/A+77.9%$194.57M$1M-5.7610High Trading Volume
LRMR
Larimar Therapeutics
1.9094 of 5 stars
$2.89
-4.6%
$18.50
+540.1%
-59.5%$194.01MN/A-1.9430
CRGX
CARGO Therapeutics
2.1148 of 5 stars
$4.12
-1.7%
$15.00
+264.1%
-71.4%$193.20MN/A-0.89116Trending News
Analyst Forecast
Gap Up
CYBN
Cybin
2.9153 of 5 stars
$8.39
+2.9%
$86.00
+925.0%
N/A$193.17MN/A-1.9250News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:IPA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners